5-HYDROXYMETHYLCYTOSINE (cas 1123-95-1): A stable or transient DNA modification?

Add time:09/29/2019    Source:sciencedirect.com

The DNA base 5-hydroxymethylcytosine (5hmC) is produced by enzymatic oxidation of 5-methylcytosine (5mC) by 5mC oxidases (the Tet proteins). Since 5hmC is recognized poorly by DNA methyltransferases, DNA methylation may be lost at 5hmC sites during DNA replication. In addition, 5hmC can be oxidized further by Tet proteins and converted to 5-formylcytosine and 5-carboxylcytosine, two bases that can be removed from DNA by base excision repair. The completed pathway represents a replication-independent DNA demethylation cycle. However, the DNA base 5hmC is also known to be rather stable and occurs at substantial levels, for example in the brain, suggesting that it represents an epigenetic mark by itself that may regulate chromatin structure and transcription. Focusing on a few well-studied tissues and developmental stages, we discuss the opposing views of 5hmC as a transient intermediate in DNA demethylation and as a modified DNA base with an instructive role.

We also recommend Trading Suppliers and Manufacturers of 5-HYDROXYMETHYLCYTOSINE (cas 1123-95-1). Pls Click Website Link as below: cas 1123-95-1 suppliers

Prev:Association of high 5-HYDROXYMETHYLCYTOSINE (cas 1123-95-1) levels with Ten Eleven Translocation 2 overexpression and inflammation in Sjögren's syndrome patients
Next:Research Report5-HYDROXYMETHYLCYTOSINE (cas 1123-95-1) is detected in RNA from mouse brain tissues)